Evidence map›Paper›PMID 32817379›Full record

ArticlemSphere2020

Tracking of Antibiotic Resistance Transfer and Rapid Plasmid Evolution in a Hospital Setting by Nanopore Sequencing.

Silke Peter, Mattia Bosio, Caspar Gross, Daniela Bezdan, Javier Gutierrez, Philipp Oberhettinger, Jan Liese, Wichard Vogel, Daniela Dörfel, Lennard Berger and 6 more

Open access · goldAbstract read
In one paragraph

Article in mSphere, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 1 synthesis or guideline pooled it, 95 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. ACCIO: An Assembly-Based Tool Enabling Plasmid Detection.medRxiv : the preprint server for health sciences · 2025
    Article
  8. Review
  9. Infection and immunity · 2025
    Review
  10. Draft genome sequences ofMicrobiology resource announcements · 2025
    Article
  11. Novel Antibacterial Approaches and Therapeutic Strategies.Antibiotics (Basel, Switzerland) · 2025
    Review
  12. Assessing the threat ofAntimicrobial agents and chemotherapy · 2025
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Towards quantifying plasmid similarity.Microbial genomics · 2024
    Review
  18. Article
  19. Genetic Diversity inMicroorganisms · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 2 countries.

Silke PeterInstitute of Medical Microbiology and Hygiene, University of Tübingen, Tübingen, Germany silke.peter@med.uni-tuebingen.de stephan.ossowski@med.uni-tuebingen.de.
Mattia Bosio *Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Caspar Gross *Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.ORCID 0000-0002-9009-5458
Daniela BezdanCentre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Javier GutierrezCNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Philipp OberhettingerInstitute of Medical Microbiology and Hygiene, University of Tübingen, Tübingen, Germany.
Jan LieseInstitute of Medical Microbiology and Hygiene, University of Tübingen, Tübingen, Germany.ORCID 0000-0003-1717-3517
Wichard VogelMedical Center, Department of Hematology, Oncology, Immunology, Rheumatology & Pulmonology, University of Tübingen, Tübingen, Germany.
Daniela DörfelMedical Center, Department of Hematology, Oncology, Immunology, Rheumatology & Pulmonology, University of Tübingen, Tübingen, Germany.
Lennard BergerInstitute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
Matthias MarschalInstitute of Medical Microbiology and Hygiene, University of Tübingen, Tübingen, Germany.
Matthias WillmannInstitute of Medical Microbiology and Hygiene, University of Tübingen, Tübingen, Germany.
Ivo GutCNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Marta GutCNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Ingo AutenriethInstitute of Medical Microbiology and Hygiene, University of Tübingen, Tübingen, Germany.
Stephan OssowskiCentre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain silke.peter@med.uni-tuebingen.de stephan.ossowski@med.uni-tuebingen.de.ORCID 0000-0002-7416-9568
German Center for Infection Research · DEUniversitat Pompeu Fabra · ESUniversity of Tübingen · DECentre for Genomic Regulation · ESBarcelona Supercomputing Center · ESGerman Cancer Research Center · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infections with multidrug-resistant bacteria often leave limited or no treatment options. The transfer of antimicrobial resistance genes (ARG) carrying plasmids between bacterial species by horizontal gene transfer represents an important mode of expansion of ARGs. Here, we demonstrate the application of Nanopore sequencing in a hospital setting for monitoring transfer and rapid evolution of antibiotic resistance plasmids within and across multiple species. In 2009, we experienced an outbreak with extensively multidrug-resistant

Indexed as

Drug Resistance, Multiple, BacterialEvolution, MolecularNanopore SequencingAnti-Bacterial Agentsbeta-LactamasesGene Transfer, HorizontalGenomicsHospitalsHumansPlasmidsPseudomonas aeruginosaSequence Analysis, DNAAnti-Bacterial Agentsbeta-LactamasesIMP-8 enzymeantimicrobial resistancegenome assemblyhorizontal gene transferIMP-8long readNanoporeNanopore sequencingpathoLogicplasmIDentplasmid-mediated resistanceplasmidsPseudomonas aeruginosasurveillance studies

Identifiers

PMID32817379
PMCPMC7440845
OpenAlexW3055603547

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.